0001410939-22-000130.txt : 20221214 0001410939-22-000130.hdr.sgml : 20221214 20221214162819 ACCESSION NUMBER: 0001410939-22-000130 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221213 FILED AS OF DATE: 20221214 DATE AS OF CHANGE: 20221214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gibney Anthony S CENTRAL INDEX KEY: 0001750132 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 221462441 MAIL ADDRESS: STREET 1: C/O ACHILLION PHARMACEUTICALS, INC. STREET 2: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: (609) 474-6755 MAIL ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 wf-form4_167105328311833.xml FORM 4 X0306 4 2022-12-13 0 0001410939 IVERIC bio, Inc. ISEE 0001750132 Gibney Anthony S C/O IVERIC BIO, INC. 8 SYLVAN WAY PARSIPPANY NJ 07054 0 1 0 0 EVP, Chief Business Officer Common Stock 2022-12-13 4 M 0 6000 0 A 17791 D Common Stock 2022-12-13 4 M 0 25000 0 A 42791 D Restricted Stock Units 2022-12-13 4 M 0 6000 0 D Common Stock 6000.0 0 D Restricted Stock Units 2022-12-13 4 M 0 25000 0 D Common Stock 25000.0 75000 D Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. This total includes 832 shares acquired by the Reporting Person on September 15, 2022, under the Registrant's 2016 Employee Stock Purchase Plan that were not previously reported. On December 13, 2021, the Reporting Person was granted 6,000 restricted stock units, which vested on the first anniversary of the grant date with respect to 100% of the shares. Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date. /s/ Todd D.C. Anderman, as Attorney-in-Fact for Anthony Gibney 2022-12-14